Pioneering work from Srivastava et al elegantly showed that gp96 isolated from tumor cells, which contains epitopes derived tumor-specific mutations, could elicit tumor-specific immune responses that were unique to the tumor cells from which the gp96 proteins were isolated44. Here, HSP90B1 is linked to neoplasm.